Matches in Nanopublications for { ?s ?p "[A truncating allele of the cell cycle checkpoint kinase CHK2 is present in 1% of the population, conferring a moderate increase in breast cancer risk, and inactivation of chk2 enhances mammary tumorigenesis in mice with targeted inactivation of brca1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 22 of
22
with 100 items per page.
- assertion description "[A truncating allele of the cell cycle checkpoint kinase CHK2 is present in 1% of the population, conferring a moderate increase in breast cancer risk, and inactivation of chk2 enhances mammary tumorigenesis in mice with targeted inactivation of brca1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP197655.RAWhZGCYCb0-jCqEwUqL8QUMIjWCp9v7JINrAynB7Mylg130_assertion description "[A truncating allele of the cell cycle checkpoint kinase CHK2 is present in 1% of the population, conferring a moderate increase in breast cancer risk, and inactivation of chk2 enhances mammary tumorigenesis in mice with targeted inactivation of brca1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP197655.RAWhZGCYCb0-jCqEwUqL8QUMIjWCp9v7JINrAynB7Mylg130_provenance.
- NP609942.RAqFHeQrg8UtH6YSViJw461D49rnPP6c7PcacVPImUE8U130_assertion description "[A truncating allele of the cell cycle checkpoint kinase CHK2 is present in 1% of the population, conferring a moderate increase in breast cancer risk, and inactivation of chk2 enhances mammary tumorigenesis in mice with targeted inactivation of brca1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP609942.RAqFHeQrg8UtH6YSViJw461D49rnPP6c7PcacVPImUE8U130_provenance.
- NP881708.RAWf_XucUtkxsHqcNHF5AdJkg8acIRCqgeFGgo6WnylL4130_assertion description "[A truncating allele of the cell cycle checkpoint kinase CHK2 is present in 1% of the population, conferring a moderate increase in breast cancer risk, and inactivation of chk2 enhances mammary tumorigenesis in mice with targeted inactivation of brca1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP881708.RAWf_XucUtkxsHqcNHF5AdJkg8acIRCqgeFGgo6WnylL4130_provenance.
- assertion description "[A truncating allele of the cell cycle checkpoint kinase CHK2 is present in 1% of the population, conferring a moderate increase in breast cancer risk, and inactivation of chk2 enhances mammary tumorigenesis in mice with targeted inactivation of brca1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[A truncating allele of the cell cycle checkpoint kinase CHK2 is present in 1% of the population, conferring a moderate increase in breast cancer risk, and inactivation of chk2 enhances mammary tumorigenesis in mice with targeted inactivation of brca1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[A truncating allele of the cell cycle checkpoint kinase CHK2 is present in 1% of the population, conferring a moderate increase in breast cancer risk, and inactivation of chk2 enhances mammary tumorigenesis in mice with targeted inactivation of brca1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[A truncating allele of the cell cycle checkpoint kinase CHK2 is present in 1% of the population, conferring a moderate increase in breast cancer risk, and inactivation of chk2 enhances mammary tumorigenesis in mice with targeted inactivation of brca1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[A truncating allele of the cell cycle checkpoint kinase CHK2 is present in 1% of the population, conferring a moderate increase in breast cancer risk, and inactivation of chk2 enhances mammary tumorigenesis in mice with targeted inactivation of brca1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP312952.RAZEPQJTxt8VqlYgd91afd1Uzc8qaWy7lIaOy1AhIdq28130_assertion description "[A truncating allele of the cell cycle checkpoint kinase CHK2 is present in 1% of the population, conferring a moderate increase in breast cancer risk, and inactivation of chk2 enhances mammary tumorigenesis in mice with targeted inactivation of brca1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP312952.RAZEPQJTxt8VqlYgd91afd1Uzc8qaWy7lIaOy1AhIdq28130_provenance.
- NP770138.RA5L1n1KltjnLRbd7vbwG413vMKcUsugUzj1_eQoSNl_M130_assertion description "[A truncating allele of the cell cycle checkpoint kinase CHK2 is present in 1% of the population, conferring a moderate increase in breast cancer risk, and inactivation of chk2 enhances mammary tumorigenesis in mice with targeted inactivation of brca1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP770138.RA5L1n1KltjnLRbd7vbwG413vMKcUsugUzj1_eQoSNl_M130_provenance.
- assertion description "[A truncating allele of the cell cycle checkpoint kinase CHK2 is present in 1% of the population, conferring a moderate increase in breast cancer risk, and inactivation of chk2 enhances mammary tumorigenesis in mice with targeted inactivation of brca1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[A truncating allele of the cell cycle checkpoint kinase CHK2 is present in 1% of the population, conferring a moderate increase in breast cancer risk, and inactivation of chk2 enhances mammary tumorigenesis in mice with targeted inactivation of brca1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP536497.RAYn3vQCdruUdg0HwLTyo3IAHDnKmuJvnyqAhIW1hXGjE130_assertion description "[A truncating allele of the cell cycle checkpoint kinase CHK2 is present in 1% of the population, conferring a moderate increase in breast cancer risk, and inactivation of chk2 enhances mammary tumorigenesis in mice with targeted inactivation of brca1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP536497.RAYn3vQCdruUdg0HwLTyo3IAHDnKmuJvnyqAhIW1hXGjE130_provenance.
- NP536491.RAB7eCkrWukL0I-Yc3kYSKJAncYwm5VOax6i4HTZn7YfM130_assertion description "[A truncating allele of the cell cycle checkpoint kinase CHK2 is present in 1% of the population, conferring a moderate increase in breast cancer risk, and inactivation of chk2 enhances mammary tumorigenesis in mice with targeted inactivation of brca1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP536491.RAB7eCkrWukL0I-Yc3kYSKJAncYwm5VOax6i4HTZn7YfM130_provenance.
- NP271491.RAA0IZDtWdyrYquBxtzu9m5cxJLYx5vA98o15VMIBeTyo130_assertion description "[A truncating allele of the cell cycle checkpoint kinase CHK2 is present in 1% of the population, conferring a moderate increase in breast cancer risk, and inactivation of chk2 enhances mammary tumorigenesis in mice with targeted inactivation of brca1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP271491.RAA0IZDtWdyrYquBxtzu9m5cxJLYx5vA98o15VMIBeTyo130_provenance.
- NP536493.RAiEBzQSQlGt3FZUbx_6-TUtLaG1oMnXukVKDsYYT_ysA130_assertion description "[A truncating allele of the cell cycle checkpoint kinase CHK2 is present in 1% of the population, conferring a moderate increase in breast cancer risk, and inactivation of chk2 enhances mammary tumorigenesis in mice with targeted inactivation of brca1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP536493.RAiEBzQSQlGt3FZUbx_6-TUtLaG1oMnXukVKDsYYT_ysA130_provenance.
- NP536492.RAGeGMqI_ZhLbPVoInCTc2EtW6OH1Kfel6fGPGPysEZg8130_assertion description "[A truncating allele of the cell cycle checkpoint kinase CHK2 is present in 1% of the population, conferring a moderate increase in breast cancer risk, and inactivation of chk2 enhances mammary tumorigenesis in mice with targeted inactivation of brca1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP536492.RAGeGMqI_ZhLbPVoInCTc2EtW6OH1Kfel6fGPGPysEZg8130_provenance.
- NP536499.RAGjNrHATxMnf-wdA5vBoHfaNu7JPDMDKQTw7iwk_UF-g130_assertion description "[A truncating allele of the cell cycle checkpoint kinase CHK2 is present in 1% of the population, conferring a moderate increase in breast cancer risk, and inactivation of chk2 enhances mammary tumorigenesis in mice with targeted inactivation of brca1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP536499.RAGjNrHATxMnf-wdA5vBoHfaNu7JPDMDKQTw7iwk_UF-g130_provenance.
- NP536494.RA8QjY8_RdTQ8XGJsH4PCDLW2AMMDiHpXlcdwisGVQ5s0130_assertion description "[A truncating allele of the cell cycle checkpoint kinase CHK2 is present in 1% of the population, conferring a moderate increase in breast cancer risk, and inactivation of chk2 enhances mammary tumorigenesis in mice with targeted inactivation of brca1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP536494.RA8QjY8_RdTQ8XGJsH4PCDLW2AMMDiHpXlcdwisGVQ5s0130_provenance.
- NP536498.RA8jW0mQ8BLcEjZjHrAaZrbf6nCA0dJ5b8nBW9lyYMU-A130_assertion description "[A truncating allele of the cell cycle checkpoint kinase CHK2 is present in 1% of the population, conferring a moderate increase in breast cancer risk, and inactivation of chk2 enhances mammary tumorigenesis in mice with targeted inactivation of brca1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP536498.RA8jW0mQ8BLcEjZjHrAaZrbf6nCA0dJ5b8nBW9lyYMU-A130_provenance.
- NP536500.RA0if7rRbN9Eiw8ddFDCw95PoNBM6TBr8r0FokHVC4iG0130_assertion description "[A truncating allele of the cell cycle checkpoint kinase CHK2 is present in 1% of the population, conferring a moderate increase in breast cancer risk, and inactivation of chk2 enhances mammary tumorigenesis in mice with targeted inactivation of brca1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP536500.RA0if7rRbN9Eiw8ddFDCw95PoNBM6TBr8r0FokHVC4iG0130_provenance.